OBI Pharma, Inc. (TPEX:4174)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
33.80
+1.05 (3.21%)
Jun 27, 2025, 1:33 PM CST

OBI Pharma Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
8,77015,38815,91015,83122,68026,213
Upgrade
Market Cap Growth
6.84%-3.28%0.50%-30.20%-13.48%5.56%
Upgrade
Enterprise Value
7,79515,52514,39612,41121,03922,895
Upgrade
Last Close Price
33.3558.5068.9968.69112.19136.79
Upgrade
PS Ratio
128.97245.51382.923360.521208.19186.06
Upgrade
PB Ratio
2.053.193.212.585.865.42
Upgrade
P/TBV Ratio
2.704.104.263.739.796.94
Upgrade
EV/Sales Ratio
114.63247.70346.492634.541120.77162.51
Upgrade
Debt / Equity Ratio
0.120.110.110.050.080.05
Upgrade
Asset Turnover
0.010.010.010.000.000.02
Upgrade
Inventory Turnover
4.865.184.802.855.241.12
Upgrade
Quick Ratio
11.327.6517.0021.718.1815.05
Upgrade
Current Ratio
12.648.3419.1022.768.7215.67
Upgrade
Return on Equity (ROE)
-57.04%-51.01%-22.83%-37.96%-39.45%-27.69%
Upgrade
Return on Assets (ROA)
-29.11%-26.32%-21.33%-23.86%-21.83%-15.49%
Upgrade
Return on Capital (ROIC)
-29.67%-27.38%-21.90%-25.05%-23.20%-16.24%
Upgrade
Earnings Yield
-26.22%-15.01%-6.58%-10.19%-6.75%-5.26%
Upgrade
FCF Yield
-23.51%-12.65%-11.03%-11.84%-5.76%-6.84%
Upgrade
Buyback Yield / Dilution
-5.63%-1.99%-3.12%-11.65%-0.18%-3.56%
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.